234 related articles for article (PubMed ID: 22795078)
1. A clinical trial primer: historical perspective and modern implementation.
Karsh LI
Urol Oncol; 2012; 30(4 Suppl):S28-32. PubMed ID: 22795078
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
3. Clinical trials integrity: a CRO perspective.
Beach JE
Account Res; 2001; 8(3):245-60. PubMed ID: 12481762
[TBL] [Abstract][Full Text] [Related]
4. Current issues in clinical research and the development of new pharmaceuticals.
Goldhammer A
Account Res; 2001; 8(4):283-91. PubMed ID: 12481798
[TBL] [Abstract][Full Text] [Related]
5. American Society of Clinical Oncology Statement on minimum standards and exemplary attributes of clinical trial sites.
Zon R; Meropol NJ; Catalano RB; Schilsky RL
J Clin Oncol; 2008 May; 26(15):2562-7. PubMed ID: 18390967
[TBL] [Abstract][Full Text] [Related]
6. The impact of escalating regulatory requirements on the conduct of clinical research.
Gordon BG; Kessinger A; Mann SL; Prentice ED
Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
[TBL] [Abstract][Full Text] [Related]
7. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
8. Operation of a radiopharmacy for a clinical trial.
Norenberg JP; Petry NA; Schwarz S
Semin Nucl Med; 2010 Sep; 40(5):347-56. PubMed ID: 20674594
[TBL] [Abstract][Full Text] [Related]
9. Clinical trials in molecular imaging: the importance of following the protocol.
Trembath L; Opanowski A;
J Nucl Med Technol; 2011 Jun; 39(2):63-9. PubMed ID: 21565960
[TBL] [Abstract][Full Text] [Related]
10. Harmonizing regulations for biomedical research: a critical analysis of the US and Venezuelan systems.
Di Tillio-Gonzalez D; Fischbach RL
Dev World Bioeth; 2008 Dec; 8(3):167-77. PubMed ID: 17488491
[TBL] [Abstract][Full Text] [Related]
11. FDA seeks tighter controls over research with human subjects.
Hershey N; Miller RD
Hosp Med Staff; 1978 Dec; 7(12):1-7. PubMed ID: 10239337
[TBL] [Abstract][Full Text] [Related]
12. Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds.
White J; Parascandola M; Bero L
Nicotine Tob Res; 2007 Nov; 9(11):1213-25. PubMed ID: 17978997
[TBL] [Abstract][Full Text] [Related]
13. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
Bramstedt KA; Kassimatis K
Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials face heightened scrutiny as science and commerce appear to merge.
Lorman AJ
J Biolaw Bus; 2001; 4(4):23-32. PubMed ID: 12751494
[TBL] [Abstract][Full Text] [Related]
15. Protection of human subjects: first biennial report on the adequacy and uniformity of federal rules and policies, and their implementation for the protection of human subjects in biomedical and behavioral research; Report of the President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Department of Health and Human Services. Notice of report for public comment.
Fed Regist; 1982 Mar; 47(60):13272-305. PubMed ID: 10298467
[TBL] [Abstract][Full Text] [Related]
16. The pharmaceutical industry's responsibility for protecting human subjects of clinical trials in developing nations.
Kelleher F
Columbia J Law Soc Probl; 2004; 38(1):67-106. PubMed ID: 16755695
[TBL] [Abstract][Full Text] [Related]
17. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
[TBL] [Abstract][Full Text] [Related]
18. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
19. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
Nightingale SL
J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
